trial

Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia

NCTId NCT00314639
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1, Phase 2 · Completed
Enrollment 30 (estimated)
Sponsored by Laval University
Primary completion 2008-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1, Phase 2
Status
Completed
Enrollment
30 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Quadruple
Start
2005-09
Primary completion
2008-06
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
modafinil

Sponsors

Laval UniversityLead Sponsor

Investigators

1
Marc-André Roy, MD,MSc,FRCPPrincipal Investigator

Sites

1 total
Québec, Canada

Linked catalysts

1
Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophren — primary completion2008-06

Facts & assertions

4 sourced
Enrollment
30
Phase
PHASE1,PHASE2
Primary Completion Date
2008-06
Status
COMPLETED
relationships
The graph out of here
drug
modafinil
drug
lead_sponsor
Laval University
company
indication
Schizophrenia
indication
Schizophrenia and Schizophrenia Spectrum Psychosis
indication
investigator
Marc-André Roy, MD,MSc,FRCP
person